Table 3.
Infectious agent (target gene) | Real-time PCR sensitivity (three runs) (reference) | RPA sensitivity (eight runs) (reference) | RPA probit 95% sensitivity (eight runs) | RPA threshold time to sensitivity limit (min) | Sensitivity LAMP (reference) |
---|---|---|---|---|---|
DNA assays | |||||
B. anthracis (pagA) | 101 to 102 (21) | 101 to 102 | 16 | 8 | 103 (27) |
B. anthracis (capC) | 102 to 103 (21) | 102 to 103 | 778 | 7 | 103 (27) |
F. tularensis (tul-4) | 102a (28) | 101 to 102 (35a) | 19 | 10 | NDc |
Y. pestis (pla) | 2a (29) | 101 to 102 | 16 | 8 | ND |
Variola virus | 101 to 102 (30) | 101 to 102 | 16 | 10 | 102b (31) |
RNA assays | |||||
Rift Valley fever virus (N) | 102 | 101 to 102 (35b) | 19 | 7 | 102 (32, 33) |
Ebola virus (NP) | 102 | 101 to 102 | 21 | 7 | 101 (34) |
Sudan virus (NP) | 101 | 101 to 102 | 17 | 8 | ND |
Marburg virus (NP) | 101 | 101 to 102 | 21 | 8 | 102 (35) |
Sigma virus (G) | 101 | 101 to 102 | 16 | 4 | ND |
Calculated from the fg value given in the source reference publication.
As determined from the monkeypox LAMP assay.
ND, not determined.